ArticleMolecular therapy. Methods & clinical development2022

mRNA-based therapy proves superior to the standard of care for treating hereditary tyrosinemia 1 in a mouse model.

Maximiliano L Cacicedo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.